Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Bischoff, Joachim; Barinoff, Jana; Mundhenke, Christoph et al.
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)ANTI-CANCER DRUGS. Bd. 30. H. 4. 2019 S. 394-401
Harter, Philipp; Sehouli, Jalid; Lorusso, Domenica et al.
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian NeoplasmsNEW ENGLAND JOURNAL OF MEDICINE. Bd. 380. H. 9. 2019 S. 822-832
Heimes, Anne-Sophie; Schmidt, Marcus; Jaekel, Joerg et al.
A retrospective analysis of immunohistochemically determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian cancer patientsARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 299. H. 1. 2019 S. 239-246
Ditsch, Nina; Untch, Michael; Thill, Marc et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019BREAST CARE. Bd. 14. H. 4. 2019 S. 224-245
Thill, Marc; Jackisch, Christian; Janni, Wolfgang et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019BREAST CARE. Bd. 14. H. 4. 2019 S. 247-255
Fruth, A; Elger, T; Lindner, C
Antikörper gegen Erythrozyten und Thrombozyten in der Schwangerschaft und deren perinatales ManagementFrauenheilkunde up2date. Bd. 13. H. 5. 2019 S. 443-456
Willershausen, Ines; Schmidtmann, Irene; Azaripour, Adriano et al.
Association between breast cancer chemotherapy, oral health and chronic dental infections: a pilot studyODONTOLOGY. Bd. 107. H. 3. 2019 S. 401-408
Wunderle, Marius; Pretscher, Jutta; Brucker, Sara Y. et al.
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancerBREAST CANCER RESEARCH AND TREATMENT. Bd. 174. H. 2. 2019 S. 453-461
Heimes, Anne-Sophie; Schmidt, Marcus
Atezolizumab for the treatment of triple-negative breast cancerEXPERT OPINION ON INVESTIGATIONAL DRUGS. Bd. 28. H. 1. 2019 S. 1-5
Stewen, K; Theis, S; Teifke, A et al.
Benigne und präinvasive Läsion der BrustFrauenheilkunde up2date. Bd. 13. H. 5. 2019 S. 423-439